Laboratory Filtration Market

The global laboratory filtration market in terms of revenue was estimated to be worth $4.1 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 8.3% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth in the laboratory filtration market can be attributed to factors such as the increased research and development investments in the pharmaceutical and biotechnology sectors, a rising trend towards membrane filtration adoption, and rise in demand for single-use filtration products along with stringent regulatory standards. However, challenges such as membrane fouling and contamination risks, alongside the need to maintain product integrity may hinder the market's growth.

Laboratory Filtration Market - Global Forecast to 2029

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Laboratory Filtration Market

Global Laboratory Filtration Market Dynamics

DRIVER: Growing adoption of membrane filtration

Membrane filtration is widely used in the life sciences industry for the separation and purification of drug components. It offers several advantages over traditional filtration methods, such as improved efficiency, higher purity, and greater versatility, making it increasingly sought after in pharmaceutical and biotech applications. Membrane filters, composed of porous materials with precise pore sizes, are capable of separating particles, microorganisms, and macromolecules based on size, shape, and charge, enabling precise control over the filtration process. Membrane filtration plays a crucial role in these processes by effectively removing impurities, microorganisms, and contaminants from biologics, vaccines, and therapeutic proteins, thereby meeting regulatory standards and ensuring patient safety. The rising pharmaceutical production, increased demand for generics in the US and European markets, and the increasing application of membrane filtration in the life sciences industry including laboratory research applications provide growth opportunities for players in the market.

RESTRAINT: Concerns related to membrane fouling

Fouling refers to the accumulation of unwanted material, such as microorganisms, proteins, or other substances, on the surface of the filter membrane, which can lead to a reduction in the flow rate and an increase in pressure drop across the filter. Fouling can occur due to a variety of factors, such as the nature of the product being filtered, the characteristics of the filter membrane, and the operating conditions of the filtration system. For example, some products may contain high levels of proteins or other substances that can bind to the filter membrane, while others may contain microorganisms that can attach to the surface of the membrane and form biofilms. The fouling of the filter membrane can have a significant impact on the increase the cost of operation,  efficiency of the filtration process, and lead to product contamination or loss. In some cases, it may even render the filtration system unusable and require the replacement of the filter membrane. These factors can negatively impact profit margins and reduce overall revenue for pharmaceutical companies using membrane filtration technologies.

OPPORTUNITY: Untapped market potential in emerging economies

Emerging countries such as India, China, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the laboratory filtration market. An increased risk of pandemics (such as swine flu and COVID-19), the booming biopharmaceutical sector in these countries, growing economic strength and population, less-stringent regulatory guidelines, and the low manufacturing cost advantage are causing market players to set up and expand their presence in these countries. The dense population of emerging economies also creates opportunities for the expansion of the pharmaceutical industry, which in turn drives the demand for laboratory filtration products.

CHALLENGE: Availability of alternative technologies

The emergence of alternative filtration technologies could hamper the growth of the laboratory filtration market. New filtration processes are being developed that can eliminate the use of membrane filtration, such as the IDEX system, a rapid diagnostic technology that does not employ membranes. Therefore, while filtration membrane manufacturers are beginning to address the need for rapid diagnostics, it is expected that IDEX will capture a majority of the microbial analysis market in the future. Membraneless filtration techniques, such as inertial microfluidics, hydrodynamic filtration, and acoustic-based filtration, rely on physical principles other than membrane separation to achieve particle separation. These techniques offer advantages such as reduced fouling, higher throughput, and simpler device design. Thus, technological developments driving the uptake of alternative filtration technologies will negatively impact the growth of the laboratory filtration market.

Global Laboratory Filtration Industry Ecosystem Analysis

The laboratory filtration market ecosystem comprises raw material suppliers, laboratory filtration product manufacturers, and end users such as pharmaceutical and biotechnology manufacturers, hospitals & clinical laboratories, and academic & research institutes. Laboratory filtration products manufacturers provide complete filtration systems or devices, including filters, filter cartridges, modules, housings, skids, or complete filtration systems, and other products.

The microfiltration segment dominated laboratory filtration industry in 2023

Based on technique, the laboratory filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques (including reverse osmosis and ion exchange). In 2023, microfiltration segment dominated the market owing to the increasing use of microfiltration membranes as a prefilter to ultrafiltration and reverse osmosis, and rising pharmaceutical and biologics R&D. The increasing emphasis on biosimilar development and manufacturing will also aid market growth. The increasing sales volume of pharmaceutical products due to the growing geriatric population and the introduction of new drugs and formulations will also support the growth of this segment.

The sterile filtration segment dominated the laboratory filtration industry in 2023:

Based on type, the laboratory filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration segment accounted for the largest market share in 2023, primarily due to the increasing focus on biomedical research, rising requirement for sterile filtration during the liquid processing of biopharmaceuticals, and the advantages of sterile filtration over non-sterile filtration. Biomedical research including studies involving cell culture, tissue engineering, and drug discovery, drives the demand for sterile filtration technologies to maintain sterile conditions and prevent cross-contamination.

North America was the largest regional market for the laboratory filtration industry in 2023.

To know about the assumptions considered for the study, download the pdf brochure

The global laboratory filtration market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. North America was the largest segment in 2023 in the laboratory filtration market, followed by Europe and the Asia Pacific. Factors such as the presence of key biopharmaceutical facilities, significant spending on r&d activities, growth in the number of biotechnology firms in the region, presence of a well-established healthcare market, among others are responsible for the largest share of this segment.

Key players in the laboratory filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Agilent Technologies, Inc. (US), Veolia Water Technologies (France), Eaton Corporation plc (Ireland), GEA Group (Germany), Avantor, Inc. (US), Alfa Laval Corporate AB (Sweden), Steris plc (US), MANN+HUMMEL International GmbH & Co. KG (Germany), Ahlstrom (Finland), GVS S.p.A. (Italy), Membrane Solutions (US), Cole-Parmer Instrument Company, LLC (US), Meissner Filtration Products, Inc. (US), Sterlitech Corporation (US), Synder Filtration, Inc. (US), Hangzhou Cobetter Filtration Equipment Co., Ltd. (China), Toyo Roshi Kaisha, Ltd. (Japan), Rephile Bioscience Ltd. (US), Kovalus Separation Solutions (US), Nupore Filtration Systems (India), Hawach (China), and Filtros Anoia (Spain).

Scope of the Laboratory Filtration Industry

This report categorizes the laboratory filtration market to forecast revenue and analyze trends in each of the following submarkets

By Product

• Filters & Filter Media
  • Membrane Filters
    • Capsule Filters
    • Syringe Filters
    • Syringeless Filters
    • Other membrane filters (Cartridge, Cassettes, Vaccum filters, Venting Filters, In-line filters)
  • Membrane sheets and Disc
  • Filter Media
  • Depth Filters
  • Other Filters (Prefilter, bag filter, filtration microplates, magnetic filter, centrifuge filter, etc.)
• Filtration Assemblies
  • Microfiltration Assemblies
  • Ultrafiltration Assemblies
  • Nanofiltration Assemblies
  • Other Assemblies (Ion exchange & Reverse osmosis assemblies)
• Filtration Accessories
  • Filter Holders
  • Filter Flasks
  • Filter Funnels
  • Filter Dispensers
  • Filter Housings
  • Vacuum Pumps
  • Seals
  • Other Filtration Accessories (Filter dryers, filter media storage bottles, tubing, clamps, canisters, stoppers, microplates, etc.)

By Material

• Filtration Membrane
  • PES
  • PVDF
  • Nylon
  • PTFE
  • MCE & CA
  • PCTE
  • Other Filtration Membrane (PP, CN,RC, Gelatin, PETE, PVC)
• Filtration Media
  • Diatomaceous Earth
  • Cellulose
  • Activated Carbon
  • Perlite
  • Other Filtration Media (Glass fiber, Quartz, borosilicate, resin binder)

By Technique

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other Techniques

By Type

• Sterile Filtration
• Non-Sterile Filtration

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospital & Clinical Laboratories

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • RoLATAM
• Middle East
  • GCC
    • Saudi Arabia
    • UAE
    • Rest of GCC
  • Rest of Middle East
• Africa

Recent Developments of Laboratory Filtration Industry:

• In October 2023, Cytiva (US) announced the opening of a 33,000 ft2 manufacturing facility in Pune, India. The new facility will manufacture bioprocessing equipment such as tangential flow, virus filtration, and inactivation systems.
• In July 2023, Avantor, Inc. announced plans to expand its Bridgewater, N.J. Innovation Center. The new Bridgewater Innovation Center’s labs will focus on upstream and downstream process development, chemistry and material science, analytical and bioanalytical, viral vector workflows and electronic materials.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst